Orient New Life Medical Co.,Ltd.

 

Quality is life.

 

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
Company News
Home ProductsHome Fertility Testing Kits

Orient New Life Medical Co.,Ltd.

Certification
Good quality Home Testing Kits for sales
Good quality Home Testing Kits for sales
We are satisfied with your quality & services so far. The HIV 1/2 antibody Test performance is perfect.

—— Katrina

I have to say that New Life provides high quality products. The FOB, Troponin I, HIV, HCV, Drug Abuse test all performed very well in our market.

—— Clemen

Your Dengue IgG/IgM and Malaria test perfromed well. Now we want to try your Filariasis test in our market.

—— Primo

I'm Online Chat Now

Blood Specimen Toxoplasmosis Test Kit Multiple Format Quantitive Detection

China Blood Specimen Toxoplasmosis Test Kit Multiple Format Quantitive Detection supplier
Blood Specimen Toxoplasmosis Test Kit Multiple Format Quantitive Detection supplier Blood Specimen Toxoplasmosis Test Kit Multiple Format Quantitive Detection supplier

Large Image :  Blood Specimen Toxoplasmosis Test Kit Multiple Format Quantitive Detection

Product Details:

Place of Origin: China
Brand Name: New Life
Certification: ISO13485, CE
Model Number: Cassette

Payment & Shipping Terms:

Minimum Order Quantity: 5000pcs
Packaging Details: 1pc/pouch, 25pcs/box
Delivery Time: 20-30days
Payment Terms: T/T, Western Union, MoneyGram
Supply Ability: 2000000pcs/month
Contact Now
Detailed Product Description
Category: Fertility Format: Multiple
Specimen: Blood Testing Time: 5-15 Minutes
Shelf Life: 24 Months Application: Toxo IgM
Sensitivity: 98.7%

One Step Toxoplasma Rapid Test for detection of IgM antibodies to Toxoplasma gondii in serum/plasma

 

 

INTENDED USE:

 

The Toxoplasma Rapid Test is a rapid qualitative lateral flow test designed for the quantitive detection of IgM antibodies to Toxoplasma gondii (TOXO) in human serum/plasma samples.

 

 

INTRODUCTION

 

T. gondii is an obligate intracellular protozoan parasite with a worldwide distribution (5, 6). Serological data indicate that approximately 30% of the population of most industrialized nations is chronically infected with the organism (7). When a seronegative woman becomes infected with T. gondii during pregnancy, the organism is often transmitted across the placenta to the fetus (5, 8). The severity of the infection in the fetus varies with the trimester during which the infection was acquired. Infection during pregnancy may lead to spontaneous abortion, stillbirth or overt diseases in the neonate. Approximately 75% of congenitally infected newborns are symptomatic. However, nearly all children born with subclinical toxoplasmosis will develop adverse ocular or neurologic sequelae later in life (8, 11). Approximately 80-85% develops chorioretinitis and some may also experience blindness or mental retardation.

A variety of serologic tests for antibodies to T. gondii have been used as an aid in diagnosis of acute infection and to assess previous exposure to the organism. The more widely used tests include the Sabin-Feldman dye test, direct agglutination, indirect hemagglutination, latex agglutination, indirect immunofluorescence, and ELISA (9, 10).

 

 

 

TEST PRINCIPLE

 

The Toxoplasma Rapid Test Device (Serum/Plasma) has been designed to detect IgM antibodies to TOXO through visual interpretation of color development in the internal strip. The membrane was immobilized with antigens of TOXO on the test region. During the test, the specimen is allowed to react with colored recombinant mouse anti-human IgM latex conjugates, which were precoated on the sample pad of the test. The mixture then moves on the membrane by a capillary action, and interacts with reagents on the membrane. If there were enough TOXO antibodies in specimens, a colored band will from at the test region of the membrane. Presence of this colored band indicates a positive result, while its absence indicates a negative result. Appearance of a colored band at the control region serves as a procedural control. This indicates that proper volume of specimen has been added and membrane wicking has occurred.

 

 

 

TEST PROCEDURE

 

1.  Bring the pouched test device to room temperature(15-30℃) prior to testing. Do not open the pouch until ready

to begin testing.

2.  Remove the device from the sealed pouch and lay it on a flat and dry surface.

3.  Using the provided pipette, add one drop of fresh specimen to the sample well.

4.  Hold the buffer bottle vertically and add 1 drop to the sample well. /If using a pipette, change a new one to avoid cross-contamination. Draw and transfer 2-3 drops of buffer to the sample well.

5. Read the result between 15-20minutes. Do not read results after 20 minutes.

 

 

INTERPRETATION OF RESULTS

 

 

Positive:

 

Two pink lines appear in the result window.

 

Negative:

 

Only one pink line appears in the control region (C).

 

Invalid:

 

No colored line appears in the control region regardless of the presence or absence of the test line.

 

 

 

PERFORMANCE STUDY

 

 

Table: TOXO Rapid Test vs. EIA Test

 

Relative Sensitivity: 98.21% (90.45%-99.95%)*

Relative Specificity: 98.33% (91.06%-99.96%)*

Overall Agreement: 98.28% (93.91%-99.79%)*

*95% Confidence Interval

  TOXO Rapid Test  
+ - Total
EIA Test + 55 1 56
- 1 59 60
  56 60 116

 

ORIENT NEW LIFE MEDICAL CO., LTD.
Contact: Jerry Meng
Email: Jerry @ newlifebiotest .com
Tel. +86 18657312116
SKYPE enetjerry

Contact Details
Orient New Life Medical Co.,Ltd.

Contact Person: Jerry Meng

Send your inquiry directly to us (0 / 3000)